Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03960398
Other study ID # 2019-CHITS-02
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 28, 2019
Est. completion date September 9, 2019

Study information

Verified date November 2019
Source Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

French population grows older year after year: 24.3% people were over 60 years old in 2006 against 20.6% in 2000 and the expected number might be over 33% in 2050.

The elderly suffer from lots of illnesses, so they usually take lots of drugs. Therefore, this drug use is most likely to have adverse drug reactions.

Finally, according to Health Ministry, the number of emergency department consultations doubled from 1996 to 2016.

Consequently, it is interesting to study the impact of drug iatrogenic effects on emergency consultations.

It would help to prevent these adverse drug reactions as we prescribe those drugs : First, do not harm.


Description:

This will be a retrospective study.

The number of patients will be defined by the number of visits during a random draw of 10 emergency department consultation days between 21st June 2018 and 22nd September 2018 in Toulon - La Seyne sur Mer public hospital.

There are between 100 and 300 emergency department consultations per day in this hospital so the estimated number of patients will be between 1000 and 3000.

Every patient who came to hospital for a consultation in emergency department during this period of time will be included in the study except those who expressed their opposition to their data collection and treatment.

Each patient will be anonymized with a code defined as follows : N(ame) L(ast name) 001 (chronological inclusion number)

Information of the patients involved in adverse drug reactions will be extracted and a description of this patient sample will be made.


Recruitment information / eligibility

Status Completed
Enrollment 2500
Est. completion date September 9, 2019
Est. primary completion date September 9, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Man or woman over 18 years old

- Consultation in emergency department of Sainte Musse or La Seyne-sur-Mer hospital between 21st june 2018 and 22nd september 2018 included

- Consultation of the patient in emergency department during the 10 day random draw of the research (from 00h01 to 23h59)

- Consultation in emergency department because of a iatrogenic reason

Exclusion Criteria:

- Dead patients

- Patient's opposition

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Iatrogenic disease impact on emergency consultations
Determination of the proportion of emergency consultations linked to iatrogenic diseases

Locations

Country Name City State
France Centre Hospitalier Intercommunal de Toulon - La Seyne sur Mer La Seyne-sur-Mer Var
France Centre Hospitalier Intercommunal de Toulon - La Seyne sur Mer Toulon Var

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Proportion of patients coming to emergency department because of an adverse drug reaction We will study each case and determine whether the consultation in the emergency department is due to adverse drug reaction or not.Number of patients having an emergency department consultation because of an adverse drug reaction divided by the total number of patients having an emergency department consultation during the same period of time. 10 days (chosen at random between 21st June and 22nd September 2018)
Secondary Average of patient age among the patients consulting because of an adverse drug reaction Average and standard deviation of patient age among the patients consulting in emergency department because of an adverse drug reaction. 10 days
Secondary Proportion of male and female patients consulting because of an adverse drug reaction Number of male and female patients consulting in emergency department because of an adverse drug reaction divided by the total number of patients consulting in emergency department because of an adverse drug reaction. 10 days
Secondary Number of treatments administered to patients who consult because of an adverse drug reaction Number of treatments patients were taking when they arrived in emergency department for a consultation because of an adverse drug reaction 1 day
Secondary Frequency of the drugs leading to a consultation in emergency department because of an adverse drug reaction For each drug leading, during the 10 chosen days, to a consultation because of an adverse reaction, number of times when this drug was at the origin of a consultation 10 days
See also
  Status Clinical Trial Phase
Recruiting NCT05017948 - Alleviating Geriatric Inpatients' Medication-related Iatrogenesis N/A
Completed NCT02572999 - Incidence and Risk Factors for Hospitalization-Associated Disability N/A
Completed NCT04314817 - Adverse Events Related to Treatments Used Against Coronavirus Disease 2019
Completed NCT04422808 - AduLt iatrogEnic withdRawal sTudy in the ICU (ALERT-ICU)
Completed NCT02165618 - Rationalisation of Polypharmacy by the Geriatric Consultation Team N/A
Completed NCT05336656 - Assessment of Analgesics and Sedatives in Mechanically Ventilated Patients With COVID-19
Recruiting NCT05639231 - An INtervention TO Improve MOBility of Older Hospitalized Patients N/A